Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check4 days agoChange DetectedThe screenshots show minor formatting adjustments and an updated last updated timestamp with no changes to the study design, eligibility criteria, interventions, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, indicating a new release with updated revision metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.0.2 (from v3.0.1); the Back to Top link was removed as a minor UI change.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new related topics such as pembrolizumab. However, several previous location details and resources have been removed.SummaryDifference3%

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.